Miracor Medical Sa
Medical Devices, Hognoul, Massachusetts, 02090, United States, 11-50 Employees
Phone Number: +17*********
Who is MIRACOR MEDICAL SA
Miracor Medical SA is a European medical device company dedicated to improve clinical outcome of patients with impaired cardiac function. Miracor develops and studies the PiCSO (Pressure-...
Read More
-
Headquarters: Hognoul, Massachusetts, 02090, United States
-
Date Founded: 2008
-
Employees: 11-50
-
Revenue: $10 Million to $25 Million
-
Active Tech Stack: See technologies
Industry: Medical Devices
Does something look wrong? Fix it. | View contact records from MIRACOR MEDICAL SA
Miracor Medical SA Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Miracor Medical SA
Answer: Miracor Medical SA's headquarters are located at Hognoul, Massachusetts, 02090, United States
Answer: Miracor Medical SA's phone number is +17*********
Answer: Miracor Medical SA's official website is https://miracormedical.com
Answer: Miracor Medical SA's revenue is $10 Million to $25 Million
Answer: Miracor Medical SA has 11-50 employees
Answer: Miracor Medical SA is in Medical Devices
Answer: Miracor Medical SA contact info: Phone number: +17********* Website: https://miracormedical.com
Answer: Miracor Medical SA is a European medical device company dedicated to improve clinical outcome of patients with impaired cardiac function. Miracor develops and studies the PiCSO (Pressure-controlled intermittent Coronary Sinus Occlusion) Impulse System, which is used as an adjunctive technique during the primary PCI procedure for acute myocardial infarction patients. PiCSO therapy seeks to improve coronary microvascular function to reduce infarct size and salvage myocardium, thereby improving outcomes of ST-elevation myocardial infarction (STEMI) patients. Recent Clinical Studies have successfully demonstrated the safety and positive effects of PiCSO on coronary microvascular function and infarct size reduction in STEMi patients. The company is conducting further clinical trials in Europe and plans to initiate a US IDE randomized controlled trial in 2023. Miracor has won several innovation awards and completed financing rounds raising venture capital and public funding. The company was founded in May 2008 by Professor Dr. Dr. Werner Mohl and the European venture capital firms Earlybird and Delta Partners.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month